The top-most executive of DePuy Orthopaedics, a business
unit of Johnson & Johnson, continues
to repudiate the damaging reasons for
which the ASR Hip System was being pulled out from the market in 2010.
Defending the company against allegations that its artificial metal hip was
defective, president Andrew Ekdahl says the claim was exaggerated.
The hip implants were recalled because they did not meet the
clinical needs of the product, Ekdahl says, downplaying claims that they were
substandard. He reaffirmed his statement
when he testified on video tape during the first of the 10,000 cases to go to
trial, before a jury at the California Superior Court in Los Angeles County
early this year.
Ekdahl, who assumed office in 2012, told the jury that there
was no truth over patient’s claims that the hip prosthesis was defectively
designed and that the company failed to warn the physicians of the risks before
the recall of the 93,000 ASR hip devices. At the time, Johnson & Johnson
said that 12 percent of the devices failed in the United Kingdom. Analysts
estimate the lawsuits might cost the company billions of dollars in settlements
and compensatory claims.
Michael Kelly, the lawyer of Loren Kransky, 65, a Montana
man whose case against DePuy was the first to go in court over his failed hip,
has repeatedly questioned Ekdahl about
whether the company removed the hips in the market because they were unsafe.
“It was taken off the
market because it did not meet the clinical needs for the product in the
marketplace,” Ekdahl said in a videotaped statement taken in December 2012 and
shown to state court jurors in Los Angeles.
New Brunswick, New Jersey-based Johnson & Johnson, the
world’s largest seller of health care products, dispelled speculations that it
had designed defective devices which has caused suffering to thousands of
patients, including Kransky.
Read more about it at: